The CelTivityTM Biopsy Systems’ captures unique data from biopsies and produces a “heat map” of highly active cells within a biopsy sample to rapidly and accurately identify cancer, immune and other cells.
Revolutionizing the digital automation of rapid on-site biopsy assessment.
Virtual contrast displayed dependent on the activity level of individual cells. No staining or biopsy preparation required.
DCI-Dynamic Cell ImagingTM captures and displays real-time cellular date from intraoperative biopsies.
CelTivityTM Biopsy System
Intended Use: An FDA Class I in vitro diagnostic medical device. CelTivityTM aims at providing a rapid on-site microscopic optical image of unstained surgical specimen immediately after resection, for review by physicians to assist in forming a clinical judgement. The benefits of using CelTivityTM are to better antici- pate patient care and to improve medical institutions’ efficiency.
CelTivityTM allows for biopsy adequacy from a fresh and unprocessed to use and delivers results in a few simple steps. The unadulterated biopsy can the be sent to pathology, along with the CeltivityTM images.
More Than Just A Pretty Picture
The results allow clinicians to intraprocedural identification and interpretation of different cell types such as cancer cells, immune cells, granuloma, and others to properly assess biopsy samples for adequacy.
This data captured allows pathology to prioritize their focus on specific areas of a sample for further examination.
The CelTivityTM Biopsy System
Aquyre brings the revolution of digital medical imaging to the cellular scale and within reach for all to use.
The technology allows the proceduralist to make real time assessments of the quality and content of their biopsy samples.
To contact a sales representative in the United States, please email Info@Aquyre.com